SAYDAM, G. Et Al. 2018. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up. HEMATOLOGY , vol.23, no.10 , 771-777.

SAYDAM, G., HAZNEDAROĞLU, İ. C., KAYNAR, L., Yavuz, A., Ali, R., GÜVENÇ, B., ... AKAY, O. M.(2018). Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up. HEMATOLOGY , vol.23, no.10, 771-777.

SAYDAM, GÜRAY Et Al. "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up," HEMATOLOGY , vol.23, no.10, 771-777, 2018

SAYDAM, GÜRAY Et Al. "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up." HEMATOLOGY , vol.23, no.10, pp.771-777, 2018

SAYDAM, G. Et Al. (2018) . "Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up." HEMATOLOGY , vol.23, no.10, pp.771-777.

@article{article, author={GÜRAY SAYDAM Et Al. }, title={Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up}, journal={HEMATOLOGY}, year=2018, pages={771-777} }